Amy Leibowitz1, Derek D Satre, Wendy Lu, Constance Weisner, Caroline Corriveau, Elio Gizzi, Stacy Sterling. 1. Division of Research, Kaiser Permanente Northern California, 2000 Broadway, 3rd Floor, Oakland, CA (AL, DDS, WL, CW, SS), Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, 401 Parnassus Avenue, San Francisco, CA (DDS), The Permanente Medical Group, Addiction Medicine and Recovery Services, 380 W MacArthur Blvd, Oakland, CA (CC), The Permanente Medical Group, East Bay Technology, 901 Nevin Avenue, Richmond, CA (EG).
Abstract
BACKGROUND AND AIMS: Unhealthy drinking is a leading threat to health, yet few people with alcohol use disorder (AUD) receive treatment. This pilot tested the feasibility of addiction medicine video consultations in primary care for improving AUD medication adoption and specialty treatment initiation. METHODS: Primary care providers (PCPs) received training and access to on-call addiction medicine consultations. Feasibility measures were training attendance, intention to use the service and/or AUD pharmacotherapy, and user feedback. Secondary outcomes were utilization, prescription and treatment initiation rates, and case reports. χ2 tests were used to compare prescription and treatment initiation rates for consult recipients and non-recipients. RESULTS: Ninety-one PCPs (71.1%) attended a training, and 60 (65.9%) provided feedback. Of those, 37 (64.9%) mentioned pharmacotherapy and 41 (71.9%) intended to use the video consult service. Of 27 users, 19 provided feedback; 12 (63.1%) rated its value at 8 or above, on a scale of 1 to 10 (average 6.9). The most useful aspect was immediacy, and users wanted an easier workflow and increased consultant availability. Of 32 patients who received a consult, 11 (34.4%) were prescribed naltrexone, versus 43 (6.4%) of non-recipients (P < 0.0001); 11 (34.4%) initiated specialty treatment, versus 105 (19.7%) of non-recipients (P < 0.05). CONCLUSIONS: PCP training attendance and feedback suggest that an addiction telemedicine consult service would be valuable to PCPs and might increase AUD medication uptake and specialty addiction treatment initiation. However, future research should include significant modifications to the piloted telemedicine model: robust staffing and simpler, more flexible methods for PCPs to obtain consults.
BACKGROUND AND AIMS: Unhealthy drinking is a leading threat to health, yet few people with alcohol use disorder (AUD) receive treatment. This pilot tested the feasibility of addiction medicine video consultations in primary care for improving AUD medication adoption and specialty treatment initiation. METHODS: Primary care providers (PCPs) received training and access to on-call addiction medicine consultations. Feasibility measures were training attendance, intention to use the service and/or AUD pharmacotherapy, and user feedback. Secondary outcomes were utilization, prescription and treatment initiation rates, and case reports. χ2 tests were used to compare prescription and treatment initiation rates for consult recipients and non-recipients. RESULTS: Ninety-one PCPs (71.1%) attended a training, and 60 (65.9%) provided feedback. Of those, 37 (64.9%) mentioned pharmacotherapy and 41 (71.9%) intended to use the video consult service. Of 27 users, 19 provided feedback; 12 (63.1%) rated its value at 8 or above, on a scale of 1 to 10 (average 6.9). The most useful aspect was immediacy, and users wanted an easier workflow and increased consultant availability. Of 32 patients who received a consult, 11 (34.4%) were prescribed naltrexone, versus 43 (6.4%) of non-recipients (P < 0.0001); 11 (34.4%) initiated specialty treatment, versus 105 (19.7%) of non-recipients (P < 0.05). CONCLUSIONS: PCP training attendance and feedback suggest that an addiction telemedicine consult service would be valuable to PCPs and might increase AUD medication uptake and specialty addiction treatment initiation. However, future research should include significant modifications to the piloted telemedicine model: robust staffing and simpler, more flexible methods for PCPs to obtain consults.
Authors: Steven M Ornstein; Peter M Miller; Andrea M Wessell; Ruth G Jenkins; Lynne S Nemeth; Paul J Nietert Journal: J Stud Alcohol Drugs Date: 2013-07 Impact factor: 2.582
Authors: Anna Lembke; Katharine A Bradley; Patricia Henderson; Rudolf Moos; Alex H S Harris Journal: J Gen Intern Med Date: 2011-04-01 Impact factor: 5.128
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Matthew E Hirschtritt; Andrea H Kline-Simon; Kurt Kroenke; Stacy A Sterling Journal: J Am Board Fam Med Date: 2018 Sep-Oct Impact factor: 2.657
Authors: James H Ford; Amanda J Abraham; Nicoleta Lupulescu-Mann; Raina Croff; Kim A Hoffman; Kelly Alanis-Hirsch; Mady Chalk; Laura Schmidt; Dennis McCarty Journal: J Stud Alcohol Drugs Date: 2017-09 Impact factor: 2.582
Authors: Cristian Ricci; Angela Wood; David Muller; Marc J Gunter; Antonio Agudo; Heiner Boeing; Yvonne T van der Schouw; Samantha Warnakula; Calogero Saieva; Annemieke Spijkerman; Ivonne Sluijs; Anne Tjønneland; Cecilie Kyrø; Elisabete Weiderpass; Tilman Kühn; Rudolf Kaaks; Maria-Jose Sánchez; Salvatore Panico; Claudia Agnoli; Domenico Palli; Rosario Tumino; Gunnar Engström; Olle Melander; Fabrice Bonnet; Jolanda M A Boer; Timothy J Key; Ruth C Travis; Kim Overvad; W M Monique Verschuren; J Ramón Quirós; Antonia Trichopoulou; Eleni-Maria Papatesta; Eleni Peppa; Conchi Moreno Iribas; Diana Gavrila; Ann-Sofie Forslund; Jan-Håkan Jansson; Giuseppe Matullo; Larraitz Arriola; Heinz Freisling; Camille Lassale; Ioanna Tzoulaki; Stephen J Sharp; Nita G Forouhi; Claudia Langenberg; Rodolfo Saracci; Michael Sweeting; Paul Brennan; Adam S Butterworth; Elio Riboli; Nick J Wareham; John Danesh; Pietro Ferrari Journal: BMJ Date: 2018-05-29
Authors: Erica A Abel; Stephanie L Shimada; Karen Wang; Christine Ramsey; Melissa Skanderson; Joseph Erdos; Linda Godleski; Thomas K Houston; Cynthia A Brandt Journal: J Med Internet Res Date: 2018-11-07 Impact factor: 5.428
Authors: Chee Kin Lam; Kara McGinnis Pilote; Ashraful Haque; Joseph Burzynski; Christine Chuck; Michelle Macaraig Journal: J Med Internet Res Date: 2018-11-20 Impact factor: 5.428